Tobacco Dependence Clinical Trial
— TABATICOfficial title:
Effectiveness of an E-mail Tracking Intervention Among the Continued Abstinence of Tobacco Consumption (TABATIC). A Randomized Controlled Multicentric Trial
Verified date | June 2014 |
Source | Jordi Gol i Gurina Foundation |
Contact | n/a |
Is FDA regulated | No |
Health authority | Spain: Comité Ético de Investigación Clínica |
Study type | Interventional |
Objectives. To evaluate the effectiveness and cost effectiveness of clinical practice guide
based intervention with two face-to-face visits and e-mail tracking compared to brief advice
to obtain continued smoking abstinence at 6 and 12 months after intervention.
Methodology. simple randomized controlled multicentric trial. All smokers (N=1064) aged 18
or older that attend by any reason to the primary care center and that have an e-mail
account and they checked it at least once a week will be invited to participate. The
enrolled participants will be randomly divided into control (N=532) and intervention group
(N=532). An intensive intervention, based on the recommendations of the clinical practice
guides, that will include six contacts (2 face-to-face and 4 by e-mail) will be applied to
the intervention group. Control group will receive brief advice.
The main dependent variable will be continued abstinence of tobacco consumption at six and
twelve months after the beginning of the intervention which will be validated by and a
carbon monoxide breathe analysis measured by a cooximeter in standard conditions. Secondary
variables will include: stage change on the quitting smoking process and evaluation of the
effectiveness on the reduction of the number of smoked cigarettes at six and twelve months
after intervention. A descriptive analysis of all variables will be done. A multivariate
analysis will be undertaken to assess differences among intervention and control group;
logistic regression for dichotomic variables and lineal regression for continuous variables.
Status | Active, not recruiting |
Enrollment | 1064 |
Est. completion date | December 2014 |
Est. primary completion date | September 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Smokers over 18 years old with an e-mail account who use frequently. (Smoker is an individual who smokes any amount of tobacco, whatever this amount it is. - E-mail regular user is the one who uses it as a way of communication at least once per week) Exclusion Criteria: - Not regular e-mail users, - patients who have diseases that advise not to stop smoking: - Terminal diseases - Serious psychiatric disorders - Active addiction to other psychoactive drugs - Patients in smoking cessation process - whatever the cause that does not allow to understand goals and methodology of the study |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)
Country | Name | City | State |
---|---|---|---|
Spain | Jordi Gol i Gurina Foundation. Research Unit of Barcelona. Lifestyles Research Group. | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Jordi Gol i Gurina Foundation | Carlos III Health Institute, Preventive Services and Health Promotion Research Network, Public Health Service of Cataluña |
Spain,
Díaz-Gete L, Puigdomènech E, Briones EM, Fàbregas-Escurriola M, Fernandez S, Del Val JL, Ballvé JL, Casajuana M, Sánchez-Fondevila J, Clemente L, Castaño C, Martín-Cantera C; Grupo Estudio TABATIC. Effectiveness of an intensive E-mail based intervention in smoking cessation (TABATIC study): study protocol for a randomized controlled trial. BMC Public Health. 2013 Apr 18;13:364. doi: 10.1186/1471-2458-13-364. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in smoking status and maintenance in smoking cessation | The term used to name long term abstinence over 6 months is continuous abstinence. | the outcome measure is studied at 6 and 12 months | Yes |
Secondary | point prevalence abstinence | In case ok not reaching abstinence, will be measured if a subject has changed of stage in "transtheoretical model of Prochaska and DiClemente". | the outcome measure is studied at 3, 6 and 12 months | Yes |
Secondary | self-reported tobacco consumption | the outcome measure is studied at 3, 6 and 12 months | Yes | |
Secondary | self-reported smoking reduction | In case not reaching abstinence | the outcome measure will be studied at 3, 6 and 12 months | Yes |
Secondary | stage of change in Prochaska cycle | the outcome measure will be studied at 3,6 and 12 months | Yes | |
Secondary | used time by professionals to achieve patients stop smoking | the outcome measure will be studied at 3, 6 and 12 months | Yes | |
Secondary | used time by participants | the outcome measure will be studied at 3, 6 and 12 months | Yes | |
Secondary | cost to get smoking help in primary care service | The estimated cost of helping people to leave smoking in regular conditions | the outcome measure will be studied at 3, 6 and 12 months | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01928719 -
Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status
|
N/A | |
Completed |
NCT01995123 -
Behavioral Activation for Smoking Cessation in PTSD
|
N/A | |
Not yet recruiting |
NCT03249428 -
E-Cigarette Inner City RCT
|
N/A | |
Recruiting |
NCT02564289 -
Cardiovascular Effects of Chronic Snus Use
|
N/A | |
Completed |
NCT01928758 -
Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders
|
N/A | |
Withdrawn |
NCT01847300 -
cSBI-M for Young Military Personnel
|
N/A | |
Completed |
NCT01428310 -
Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
|
Phase 1 | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Recruiting |
NCT00977249 -
Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT00968513 -
Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry
|
Phase 3 | |
Completed |
NCT01113424 -
Bioequivalence Between Nicotine Replacement Products and Nicorette® Gum
|
N/A | |
Completed |
NCT00747643 -
Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement
|
N/A | |
Completed |
NCT00722124 -
S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence
|
Phase 2/Phase 3 | |
Completed |
NCT01238627 -
Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mg
|
N/A | |
Completed |
NCT01228617 -
Single-dose Pharmacokinetics of Oral Nicotine Replacement Products
|
N/A | |
Completed |
NCT00296647 -
Smoking Cessation Intervention: Effectiveness in Primary Care
|
Phase 4 | |
Completed |
NCT00394420 -
Emergency Department Telephone Quitline
|
N/A | |
Recruiting |
NCT05487807 -
Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia
|
Phase 1 | |
Completed |
NCT03553992 -
An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers
|
N/A | |
Withdrawn |
NCT05440721 -
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
|
N/A |